Industry leaders from across the globe have their views on the booming Orphan Drug industry, and both big pharma and start-ups are seeking to get that coveted designation. This E-book is a compilation of 17 of the top trends as spoken about by industry, payers, regulators, and patient groups around the world compiled into an easily accessible format. Industry leaders have this book, and it has helped continue to propel them forward.
What the book covers:
- Trends impacting the pharma sector
- How patient groups are changing the face of the industry
- How payers and regulators are dealing with an increase in orphan designations
- Pricing challenges and sustainability.
These topics and more will be discussed at this year’s upcoming World Orphan Drug Congress USA 2015.